Loading
companiesCompany
Dignitana
Dignitana makes the DigniCap scalp cooling system, the first cooling cap the US FDA allowed on the market, in 2015, to reduce chemotherapy hair loss.
Overview
Dignitana, a Swedish company listed on Nasdaq First North, developed the DigniCap, a silicone cap with circulating coolant and temperature sensors; it received FDA marketing authorisation in December 2015 for breast cancer patients, extended to solid tumours in 2017, and is used in cancer centres in the United States, Europe and Asia under service agreements.
Similar pages
- CompanyPaxman
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types), Cytotoxic chemotherapy and the tag machines-wave2.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types).
- CompanyMammotome (Danaher)
Shares Breast cancer (all types) and the tag machines-wave2.
- CompanyLoccioni
Shares Cytotoxic chemotherapy and the tag machines-wave2.
- CompanyPyrexar Medical
Shares Breast cancer (all types) and the tag machines-wave2.
- CompanyLightpoint Medical
Shares Breast cancer (all types) and the tag machines-wave2.
- CompanyIGEA
Shares Breast cancer (all types) and the tag machines-wave2.
- TechnologyClosed-system transfer devices for hazardous drugs (PhaSeal, ChemoLock, Equashield)
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types), Cytotoxic chemotherapy and the tag machines-wave2.